Increased prevalence of vision problems in school children during COVID-19 lockdown



Myopia is a common vision condition, also known as nearsightedness, of which limited time spent outdoors and screen time are major risk factors. A prospective study led by researchers at Tianjin Medical University found that the prevalence of myopia increased 1.4 to 3 times in Chinese children aged 6-8 years during COVID-19 quarantine, compared with the previous 5 years.


The cross-sectional study compared school-based photoscreenings of 123,535 children from 2015-2019 to 2020 after schools reopened. During the 5-month school closure period from January 2020, online learning was offered for 1 hour a day for students in grades 1-2 and for 2.5 hours for those in grades 3-6.


Myopia was 3 times higher for children aged 6 years old, 2 times higher in those aged 7 years, and 1.4 times higher in those aged 8 years. Although older children (9-13 years) were offered online courses for a longer time each day, the prevalence of myopia was less pronounced.


Why it matters: The COVID-19 pandemic has impacted health in many ways and although quarantine measures and social distancing are crucial, the study findings suggest the need for careful planning of indoor activities for young children who may be more sensitive to environmental changes. Further implications include shaping guidelines on eye health and early intervention to prevent widespread myopia, particularly during quarantine confinement.


Source: JAMA Opthalmology

The Medical Reporter

News for healthcare enthusiasts

The information contained in this website is for general informational purposes only and not intended or implied to serve as a substitute for professional medical advice, diagnosis or treatment. The Medical Reporter assumes no responsibility for any inaccuracies of the information on this website which is subject to change without notice. Please always seek the guidance of your doctor or other qualified health professionals with any questions you may have regarding your health or medical condition.

©2020 CopperMed Health Ltd. All rights reserved.